QWQinghua Wu

Qinghua Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qinghua Wu has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Huirong Shi

    Department of Obstetrics and Gynecology, Center of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    8 shared publications
  • Saisai Yang

    Department of Obstetrics and Gynecology, Center of Genetics and Prenatal Diagnosis, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    7 shared publications
  • Shumin Ren

    Department of Obstetrics and Gynecology, Center of Genetics and Prenatal Diagnosis, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    7 shared publications
  • Xiangdong Kong

    Department of Obstetrics and Gynecology, Center of Genetics and Prenatal Diagnosis, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    7 shared publications
  • Zhihui Jiao

    Department of Obstetrics and Gynecology, Center of Genetics and Prenatal Diagnosis, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    7 shared publications
  • Can Wang

    3 shared publications

Latest Publications

  • Open Access

    Association of Inflammatory markers with pregnancy loss: Global Burden (1990-2021) and NHANES survey (2005-2016)

    by Saisai Yang, Huirong Shi, Shumin Ren, Yibing Chen, Xiaoqing Jin, Liping Han, Qinghua Wu

    This study systematically characterized the global burden of pregnancy loss from 1990 to 2021 and evaluated the association between inflammatory markers and pregnancy loss, aiming to reduce the risk of pregnancy loss. A comprehensive analysis was conducted, encompassing the incidence, deaths, disability-adjusted life years (DALYs), and years lived with disability (YLDs), across a total of 204 countries. This analysis was complemented by the implementation of joinpoint regression and ARIMA models, which were utilized to assess trends and projections. Additionally, inflammatory markers were analyzed in a cohort of 5,517 U.S. women. The association between inflammatory markers and pregnancy loss was assessed using survey-weighted multivariate logistic regression. Subsequently, restricted cubic spline (RCS) plots were utilized to explore the non-linear association between inflammatory markers and pregnancy loss. Subgroup analyses were conducted to further elucidate the effects of other covariates on the association between inflammatory markers and pregnancy loss. Globally, the incidence of pregnancy loss has been observed to decline at a rate of 1.5% per annum, with a concomitant decrease in mortality of 64.8% from 1990 to 2021. The regions exhibiting the highest-burden were those with a low socio-demographic index (SDI), with an average age-standardized incidence rate (ASIR) of 1,715.1 per 100,000. In contrast, High SDI regions demonstrated rates below 500 per 100,000. Projections indicate a continued global decline to 725.2 cases/100,000 by 2032, though High SDI regions may face rising rates (3.66% annually). A U-shaped association between neutrophil-to-lymphocyte ratio (NLR) and miscarriage risk was revealed by NHANES analysis, with moderate NLR levels (the third quartile-the fourth quartile) linked to reduced odds (OR: 0.75–0.76, p < 0.05). Subgroup analyses revealed stronger associations in women aged ≤ 35 years and those with a Body Mass Index (BMI) of 25–30 kg/m2. These findings challenge the notion of linear inflammatory risk, emphasizing immune homeostasis’s role in pregnancy maintenance. The study underscores persistent disparities in low-resource settings and advocates for integrating inflammatory markers into clinical risk stratification. Public health strategies must address inequities through targeted antenatal care, while high-income regions require interventions targeting delayed childbearing and metabolic health. This dual approach may mitigate the evolving global burden of pregnancy loss.


    • 10 November 2023
      • Vol. 40  (11) , 1436-1440

    [Advances in research on the clinical phenotype and genetic etiology of jaundice associated with Hereditary bilirubin metabolic disorders].

    by Beibei Ma, Qinghua Wu

    Hereditary bilirubin metabolic disorder is an important cause for jaundice. For its diverse types and similar clinical manifestations, it has been difficult to make a clear etiological diagnosis. The application of next generation sequencing in recent years has delineated the more and more genetic etiologies for jaundice. This article has reviewed the clinical manifestations and genetic etiology of bilirubin metabolic disorder jaundice, with an aim to enhance the understanding of such diseases and facilitate their clinical diagnosis and treatment, which will provide a reference for genetic counseling and/or prenatal diagnosis for the affected individuals and families.


  • Open Access

    A novel mutation of KCNJ1 identified in an affected child with nephrolithiasis

    by Saisai Yang, Guanghui Yao, Xin Chen, Huirong Shi, Chihhong Lou, Shumin Ren, Zhihui Jiao, Cong Wang, Xiangdong Kong, Qinghua Wu

    Nephrolithiasis is not common in children, but the incidence is gradually increased in these years. Urinary tract malformations, urinary infection, dietary habits, geographic region and genetic factor are involved in the etiology of nephrolithiasis. For the affected child, it is especially important to elucidate the etiology, which may provide an accurate diagnosis, a personalized therapy and effective follow-up strategy. Here to seek the etiology of a ten-year-old boy incidentally found with nephrolithiasis, next generation sequencing (NGS) including a panel with 248 genes involved in hereditary kidney diseases was performed for the boy and identified two mutations of KCNJ1, c.89G > A (p.C30Y) and c.65G > T (p.R22M), and the later was a novel missense mutation originated from his father. The child was confirmed with type II Bartter syndrome (BS) caused by KCNJ1 mutations. Our study suggests that BS may be difficult to get diagnosed at an early stage based on clinical manifestations or biochemical laboratory tests, and NGS is an efficient way to determine the etiology and provide further treatment and guide fertility counseling for the affected family.


  • Open Access

    A Novel Mutation of KCNJ1 Identified in an Affected Child with Nephrolithiasis

    by Qinghua Wu, Saisai Yang, Huirong Shi, Chihhong Lou, Shumin Ren, Zhihui Jiao, Cong Wang, Xiangdong Kong

    Nephrolithiasis is not common in children, but the incidence is gradually increased in these years. Urinary tract malformations, urinary infection, dietary habits, geographic region and genetic factor are involved in the etiology of nephrolithiasis. For the affected child, it is especially important to elucidate the etiology, which may provide an accurate diagnosis, a personalized therapy and effective follow-up strategy. Here to seek the etiology of a ten-year old boy incidentally found with nephrolithiasis, next generation sequencing (NGS) including a panel with 248 genes involved in hereditary kidney diseases was performed for the boy and identified two mutations of KCNJ1, c.89G>A (p.C30Y) and c.65G>T (p.R22M), and the later was a novel missense mutation originated from his father. The child was confirmed with type II Bartter syndrome (BS) caused by KCNJ1 mutations. Our study suggests that BS may be difficult to get diagnosed at early stage based on clinical manifestations or biochemical laboratory tests, and NGS is an efficient way to determine the etiology and provide further treatment and guide fertility counselling for the affected family.

    • 10 May 2020
      • Vol. 37  (5) , 559-562

    [Ultrasonographic manifestation and genetic analysis of a fetus with nephronophthisis type 2].

    by Qinghua Wu, Saisai Yang, Can Wang, Huirong Shi, Shumin Ren, Zhihui Jiao, Xiangdong Kong

    To carry out genetic analysis for a family with a fetus manifesting bilateral polycystic renal dysplasia and oligohydramnios at 16+ gestational week and a previous history for fetal renal anomaly. Ultrasound scan was carried out to detect the morphological changes. Following genetic counselling, the parents had decided to terminate the pregnancy. Fetal kidneys were subjected to histological examination. Target capture and next generation sequencing (NGS) was applied to the abortus to detect potential variants. The results were verified by Sanger sequencing. Histological examination of fetal kidneys revealed cystic changes without cortex, medulla or normal renal structure. NGS has identified a heterozygous c.100+1G>A variant and deletion of exon 3 of the INVS gene, which were respectively inherited from the mother and father. Through NGS and Sanger sequencing, the fetus was diagnosed with type II nephronophthisis (NPHP2). Above result can provide guidance for further pregnancy and enforce understanding of clinical features and genetic etiologies for NPHP.


    • 10 April 2020
      • Vol. 37  (4) , 397-400

    [Clinical phenotype and genetic analysis of three pedigrees with 17q12 microdeletion syndrome].

    by Qinghua Wu, Saisai Yang, Can Wang, Huirong Shi, Xiangdong Kong, Shumin Ren, Zhihui Jiao, Ning Liu, Panlai Shi

    To explore the genetic etiology of three pedigrees with a gestational history of fetal renal anomalies. Peripheral venous blood or skin samples were derived from the probands of the three pedigrees. Copy number variation sequencing (CNV-seq) was applied to detect alterations of genome CNVs. The patient from pedigree 1 and the fetuses from pedigrees 2 and 3 all carried a heterozygous 17q12 deletion, with the size ranging from 1.4 Mb to 1.48 Mb encompassing the HNF1B gene. The diagnosis of 17q12 microdeletion may be difficult during fetal period for its variable phenotypes. Alterations of chromosomal copy numbers need to be excluded in such patients.


    • 10 December 2019
      • Vol. 36  (12) , 1153-1157

    [Phenotype and genetic analysis of three patients with PKHD1 associated autosomal recessive polycystic kidney disease at childhood, teenage and advanced age].

    by Qinghua Wu, Can Wang, Saisai Yang, Huirong Shi, Xiyang Ma, Xiangdong Kong, Shumin Ren, Zhihui Jiao, Yiwen Zhai

    The phenotype and genetics of three patients with autosomal recessive polycystic kidney disease (ARPKD) at childhood, teenage and advanced age were analyzed. Next generation sequencing (NGS) was applied to all the probands. PCR and Sanger sequencing were used to verify the suspicious gene variants screened by NGS in the probands and their family members, and one of the family got prenatal diagnosis. Through NGS, PCR and Sanger sequencing, the 5-yr proband in pedigree 1 was shown to carry compound heterozygous variants of c.5935G>A(p.G1979R) and c.5428G>T(p.E1810X) of PKHD1, originated from his parents; In pedigree 2, the 17-ys proband was detected with c.5512T>C(p.Y1838H) and c.5935G>A(p.G1979R) variants of PKHD1 orginated from her parents, and her mother also got prenatal diagnosis during the second trimester; In pedigree 3, the 70-ys female proband was found with variants c.11314C>T (p.R3772X) and c.3860T>G (p.V1287G) of PKHD1. The three pedigrees were diagnosed as ARPKD caused by PKHD1 variants. Five types of variants were detected, c.5935G>A and c.11314C>T were the known pathogenic variants, while c.5512T>C, c.5428G>T and c.3860T>G were not reported previously. Considering the complexity of the genetics and phenotypes of the cystic renal diseases, genetic diagnosis is crucial to give accurate etiological diagnosis, which may benefit the clinic management.

    • 10 February 2019
      • Vol. 36  (2) , 151-153

    [Two cases of rare diseases with abnormalities of X chromosome].

    by Qinghua Wu, Xiyang Ma, Xiangdong Kong, Huirong Shi, Zhengguang Chen, Zhihui Jiao, Lina Liu, Miao Jiang

    To explore the clinical features and genetic diagnosis of two cases with rare diseases and X chromosome abnormalities. Multiple ligation-dependent probe amplification (MLPA) and karyotype analysis were carried out on an 8-year-old girl who was diagnosed with Duchenne muscular dystrophy. Karyotype analysis and PCR assay for SRY and AZF genes were carried out for a-2-month-old male infant with short penis. The girl, who featured short stature and cubitus valgus, was diagnosed as Turner syndrome with a karyotype of 46,X,i(Xq). The male infant was detected with a karyotype of 45,X, with presence of SRY gene but absence of AZF gene. Both cases may be associated with abnormalities of X chromosome. Genetic testing can facilitate early diagnosis and clinical intervention for such patients.


  • Open Access

    Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells

    by Juan Du, Hui-Rong Shi, Fang Ren, Jing-Lu Wang, Qing-Hua Wu, Xia Li, Rui-Tao Zhang

    This study was aimed at investigating whether metformin can reverse the resistance of ovarian cancer cells to cisplatin and exploring the underlying mechanism. Ovarian cancer cell proliferation in vitro was evaluated using a CCK-8 assay. The resistance index of platinum-resistant ovarian cancer cells was determined and cell cycle and apoptosis rate determined by annexin V/propidium iodide double-staining in CP70 cells. Western blotting was used to determine IGF1, IGF1R, AKT, p-IGF1, p-IGF1R, p-AKT, and MRP2 levels in cells treated with different concentrations of metformin and LY29400, an inhibitor of the insulin-like growth factor pathway. Changes in gene expression levels of MRP2, IGF1, IGF1R, and AKT were determined by fluorescence real-time quantitative PCR assay of CP70 cells treated with metformin. Tumors of human ovarian cancer cell lines CP70 and A2780 were established by subcutaneous transplantation of cells in nude mice and the effect of metformin on MRP2 expression and tumor inhibition assessed. The IC50 value of cisplatin in CP70 cells decreased significantly as metformin concentration increased (P < 0.05). The cell cycle distribution in CP70 cells changed with metformin treatment; the percentage of cells in the G0/G1 phase, as well as the natural apoptosis rate was significantly increased with metformin treatment (P < 0.05). IGF1, IGF1R, AKT p-IGF1, p-IGF1R, and p-Akt protein expression was enhanced dose-dependently with metformin, and was also significantly changed by treatment of CP70 cells with 0 mM metformin +10 mM LY294002. Moreover, changes in the expression of MRP2, IGF1, IGF1R, and AKT was metformin-concentration dependent, and was significantly different from that in the untreated control group (P < 0.05). In nude mice, the tumor volumes of the cisplatin-treated groups were significantly less than in the control group, and was further suppressed by co-treatment with cisplatin and metformin (P < 0.05), indicating that these 2 drugs had a synergistic effect on tumor inhibition. Metformin can improve the sensitivity of ovarian cancer CP70 cells to cisplatin in a concentration-dependent manner by activating the AKT signaling pathway, inhibiting the IGF1R signaling pathway, and reducing MRP2 expression.


  • Open Access

    Outcome of Pregnancies After Balloon Occlusion of the Infrarenal Abdominal Aorta During Caesarean in 230 Patients With Placenta Praevia Accreta

    by Qinghua Wu, Zhuan Liu, Xianlan Zhao, Cai Liu, Yanli Wang, Qinjun Chu, Xiaojuan Wang, Zhimin Chen

    Purpose To explore the efficacy and safety of prophylactic temporary balloon occlusion of the infrarenal abdominal aorta during caesarean for the management of patients with placenta praevia accreta. Methods Two hundred and sixty-eight cases of placenta praevia accreta from January 2012 to June 2015 were retrospectively reviewed. Group A included two hundred and thirty patients who underwent prophylactic temporary balloon occlusion of infrarenal abdominal aorta followed by caesarean section. Group B included thirty-eight patients who underwent caesarean without endovascular intervention. The parameters including operating room time, estimated blood loss, blood transfusion volume, PT (prothrombin time) during operation, days in the intensive care unit, and total hospital days were compared between the two groups. Results The operating room time, estimated blood loss, PT, the incidence of hysterectomy, blood transfusion volume, postpartum haemorrhage, and days in intensive care unit were lower in group A than in group B, with statistical significance (P < 0.05). There was no significant difference in the Apgar scores of the neonates and the incidences of thrombosis in lower limbs between the two groups (P > 0.05). No patient in the group with prophylactic temporary balloon occlusion of the infrarenal abdominal aorta was performed hysterectomy, while three patients in group B were performed hysterectomy because of uncontrollable haemorrhage. Conclusions The results indicate that prophylactic temporary balloon occlusion of infrarenal abdominal aorta followed by caesarean section is safe and effective to control intraoperative blood loss and greatly decreases the risk of hysterectomy in patients with placenta praevia accreta.